Agios Pharmaceuticals, Inc. (AGIO) |
| 42.43 -0.17 (-0.4%) 10-09 16:00 |
| Open: | 42.65 |
| High: | 43.21 |
| Low: | 41.92 |
| Volume: | 514,441 |
| Market Cap: | 2,465(M) |
| PE Ratio: | 3.76 |
| Exchange: | NASDAQ Global Select |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 50.47 |
| Resistance 1: | 43.21 |
| Pivot price: | 39.55 |
| Support 1: | 38.12 |
| Support 2: | 34.97 |
| 52w High: | 62.58 |
| 52w Low: | 23.42 |
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Financials
| EPS | -283900000.000 |
| Book Value | 11.290 |
| PEG Ratio | 0.00 |
| Gross Profit | 37.867 |
| Profit Margin (%) | 1.00 |
| Operating Margin (%) | 590.42 |
| Return on Assets (ttm) | -1.0 |
| Return on Equity (ttm) | 20.1 |
Company news
Wed, 08 Oct 2025
Agios Pharmaceuticals' (AGIO) Hold (C-) Rating Reiterated at Weiss Ratings - MarketBeat
Wed, 08 Oct 2025
Agios Pharmaceuticals (NASDAQ:AGIO) Cut to "Strong Sell" at Zacks Research - MarketBeat
Fri, 03 Oct 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO - WV News
Thu, 18 Sep 2025
AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire
Mon, 08 Sep 2025
Agios Pharmaceuticals: Why A Delayed FDA Review Could Still Be A Positive (NASDAQ:AGIO) - Seeking Alpha
Sun, 07 Sep 2025
Biotech Stocks Facing FDA Decision In September 2025 - RTTNews
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
